Investigating the Benefits of Probiotics in Treating Irritable Bowel Syndrome

Author(s):Dr Amir Hussain

Received: 2019-09-14 Accepted: 2019-10-01 Published: 2019-10-15

Abstract

Background: Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits. Despite the availability of various treatments, management remains challenging for many patients. Probiotics, live microorganisms that confer health benefits to the host, have been investigated for their potential role in alleviating IBS symptoms. This study aims to evaluate the effectiveness of probiotics in reducing IBS symptoms compared to conventional treatments.
Methods: A randomized controlled trial was conducted with 250 participants (aged 18–65 years) diagnosed with IBS. Participants were randomly assigned to three groups: a probiotic group, a fiber supplementation group, and a pharmacotherapy group. Symptom severity was assessed using the IBS Severity Scoring System (IBS-SSS) and the Bristol Stool Scale (BSS) at baseline, 6 weeks, and 12 weeks.
Results: The probiotic group showed a 45% reduction in IBS-SSS scores, compared to 30% in the fiber group and 28% in the pharmacotherapy group. The probiotic group also exhibited improvements in stool consistency and reduced bloating.
Conclusion: Probiotics demonstrated significant benefits in treating IBS, with improvements comparable to traditional treatments. Probiotics should be considered a viable option in the management of IBS symptoms, especially for patients who prefer non-pharmacological treatments.

Keywords: Irritable Bowel Syndrome, Probiotics, Fiber Supplementation, Pharmacotherapy, IBS Severity Scoring System, Bristol Stool Scale

Download PDF